T-cell subset biomarkers across the rheumatoid arthritis disease continuum: from clinical utility to adoption in daily practice.

This was associated with a possible trend for increase in naive cell over the duration of remission ( Fig. 5b , rho = 0.200, P = 0.0014) from first achieving DAS28 < 2.6 to stable remission for several years.

also in 1,410 other papers